Biochemical Studies of a Transcription Factor

转录因子的生化研究

基本信息

  • 批准号:
    8118570
  • 负责人:
  • 金额:
    $ 30.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-01 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Development in metazoans is regulated by specific regulatory hierarchies leading to the stage- and tissue-specific expression of transcriptional networks. Understanding such networks poses a major challenge in developmental biology. A model is provided by the regulation of sexual dimorphism in Drosophila melanogaster. This collaborative R01 application from the laboratories of M. Weiss (CWRU) and B. Baker (Stanford) focuses on Doublesex (DSX), a member of a newly recognized family of DM transcription factors broadly involved in metazoan development, including in humans. Our long-term goal is a molecular understanding of how information is transmitted from the primary determinants of sex to the genes responsible for the morphological, biochemical, and behavioral differences between the sexes. The doublesex (dsx) gene controls a major branch of the sex-determining hierarchy of D. melanogaster. The doublesex (dsx) gene encodes sex-specific protein isoforms (designated DSXF (female) and DSXM (male)) as a consequence of sex-specific RNA splicing. Although DSXF and DSXM have opposing biological functions, they exhibit similar DNA-binding properties and so presumably recognize the same cis- acting control elements in target genes. DSXF (but not DSXM) interacts with transcriptional coactivator Intersex (IX), presumably leading to assembly of a female-specific multiprotein-DNA complex at target genes. Such sex-specific regulatory properties presumably underlie the function of dsx as a prototypical "behavioral gene" in the nervous system: DSXM regulates sine singing, a component of the male courtship song, whereas DSXF is hypothesized to regulate major features of female courtship behavior, including rejection behavior. We seek to investigate the molecular bases of the sex-specific functions of DSXF and DSXM with application to behavioral genetics. To these ends, an innovative interdisciplinary strategy is proposed that integrates molecular genetics with biochemistry, proteomics, and structural biology. Studies will focus on the respective C-terminal domains of DSXF/M containing sex-specific tails. In addition, newly described methods for gene targeting in vivo will be employed to investigate the relationship between dsx as a behavioral gene and a discrete and quantifiable repertoire of behavioral elements. Because deletions of DSX-related genes in human chromosome 9 are associated with intersexual abnormalities of the newborn, our results may also provide insight into a major class of human birth defects. Public Health Relevance: How the differences between male and female animals are specified by genes defines a major scientific problem. We are studying sex-specific genes in fruit flies to gain insight into human birth defects, infertility syndromes, and cancers of the gonads.
描述(由申请人提供):后生动物的发育受特定的调控等级调节,导致转录网络的阶段和组织特异性表达。理解这样的网络是发育生物学的一个重大挑战。黑腹果蝇性别二态性的调节提供了一个模型。这项来自M. Weiss (CWRU)和B. Baker (Stanford)实验室的合作R01申请专注于double - esex (DSX),这是一个新发现的DM转录因子家族的成员,广泛参与后生动物的发育,包括人类。我们的长期目标是从分子上理解信息是如何从性别的主要决定因素传递到负责两性之间形态、生化和行为差异的基因的。双性(dsx)基因控制着d.m anogaster性别决定等级的一个主要分支。作为性别特异性RNA剪接的结果,双性(dsx)基因编码性别特异性蛋白质亚型(指定为DSXF(女性)和DSXM(男性))。虽然DSXF和DSXM具有相反的生物学功能,但它们表现出相似的dna结合特性,因此可能在靶基因中识别相同的顺式作用控制元件。DSXF(但不是DSXM)与转录共激活因子Intersex (IX)相互作用,可能导致靶基因上女性特异性多蛋白- dna复合物的组装。这种性别特异性调节特性可能是dsx作为神经系统中典型“行为基因”功能的基础:DSXM调节雄性求偶歌曲的一个组成部分——正弦鸣叫,而DSXF被假设调节雌性求偶行为的主要特征,包括拒绝行为。我们试图研究DSXF和DSXM性别特异性功能的分子基础,并将其应用于行为遗传学。为此,提出了一种创新的跨学科策略,将分子遗传学与生物化学、蛋白质组学和结构生物学相结合。研究将集中在DSXF/M含有性别特异性尾巴的c端结构域。此外,新描述的体内基因靶向方法将用于研究dsx作为行为基因与离散和可量化的行为元素之间的关系。由于人类9号染色体上dsx相关基因的缺失与新生儿的性间性异常有关,我们的研究结果也可能为人类出生缺陷的主要类别提供见解。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Aaron WEISS其他文献

MICHAEL Aaron WEISS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Aaron WEISS', 18)}}的其他基金

Biochemical Studies of a Transcription Factor
转录因子的生化研究
  • 批准号:
    8004618
  • 财政年份:
    2010
  • 资助金额:
    $ 30.79万
  • 项目类别:
How Insulin Binds to the Insulin Receptor
胰岛素如何与胰岛素受体结合
  • 批准号:
    8003136
  • 财政年份:
    2010
  • 资助金额:
    $ 30.79万
  • 项目类别:
Design of an Implantable Pump Insulin
植入式胰岛素泵的设计
  • 批准号:
    8003137
  • 财政年份:
    2010
  • 资助金额:
    $ 30.79万
  • 项目类别:
Clinical Testing of an Insulin Analog
胰岛素类似物的临床测试
  • 批准号:
    7613905
  • 财政年份:
    2009
  • 资助金额:
    $ 30.79万
  • 项目类别:
Design of an Implantable Pump Insulin
植入式胰岛素泵的设计
  • 批准号:
    7795721
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:
Biochemical Studies of a Transcription Factor
转录因子的生化研究
  • 批准号:
    7665133
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:
Biochemical Studies of a Transcription Factor
转录因子的生化研究
  • 批准号:
    7522890
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:
Design of an Implantable Pump Insulin
植入式胰岛素泵的设计
  • 批准号:
    7600456
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:
Biochemical Studies of a Transcription Factor
转录因子的生化研究
  • 批准号:
    7901159
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:
Design of an Implantable Pump Insulin
植入式胰岛素泵的设计
  • 批准号:
    8055273
  • 财政年份:
    2008
  • 资助金额:
    $ 30.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了